Lab unveils ‘Heart-on-a-Chip’

Through “-on-a-chip” technology—modeling a human heart on an engineered chip and measuring the effects of compound exposure on functions of  using microelectrodes—Lawrence Livermore National Laboratory (LLNL) researchers hope to decrease the time needed for new drug trials and ensure potentially lifesaving drugs are safe and effective while reducing the need for human and animal testing. The research is part of the Lab’s iCHIP (in-vitro Chip-Based Human Investigational Platform) project, which replicates human systems on engineered platforms to test the effects of toxic chemical and biological compounds.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *